Prof. Vinoth-Kumar Lakshmanan Ph.D
Toronto Metropolitan University, Sri Ramachandra Institute of Higher Education and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)
About
Dr. Vinoth-Kumar Lakshmanan is a Senior Investigator and Professor for Prostate Cancer Biomarker Laboratory, Faculty of Clinical Research at Sri Ramachandra Institute of Higher Education and Research (DU), India and Adjunct Professor of Department of Mechanical, Industrial and Mechatronics Engineering, Faculty of Engineering and Architectural Science, Toronto Metropolitan University, Canada.
He obtained Ph.D from University of Strasbourg, France, Post Doctoral from University of Regensburg and Karlsruhe Institute of Technology (KIT), Germany.
After post -PhD cumulating 19 years international faculty experiences from Medical Universities Amrita, Chonnam, Gulf he engaged in identifying good biomarkers for cancer and this led him to determine the role of secretory protein in prostate cancer, how they might contribute to metastasis.
He also studied loss and gain of function using inducible strategy in the cell lines. The goal is to develop a mouse metastatic xeno-graft model in which he could see a tumor affecting the organ in which cancer could be studied.
His research interests include the biological studies of Cancers especially Prostate, Nano Drug delivery and development of xenograft and Knock out animal models for understanding cancer progression.
Moreover, he is also interested in medical implant products with biodegradable, Non-toxic, bioresorbable and low-cost CART and Organ-on-a-Chips (OoCs).
In addition, he does clinical trials for Prostametrix devices and understands the role of urinary biomarkers for early prostate cancer detection.
He also gained research experience from the International Centre for Genetic Engineering and Biotechnology (ICGEB) India, a United Nations Industrial Development Organization (UNIDO).
Currently, he serves as Chief Scientific Advisor for Delta Botanicals and Research Limited.
He published dozens of publications and multiple patents, and he does serve reviewers for many international peer reviewed journals and editorial board members for Nature Scientific Reports.
He is a recipient of Association pour de la researche de cancer French fellowship and Life member of Indian association of Cancer research.
He is a recipient of the Department of Science and Technology fast track scientist investigator award and Core Research Grant (CRG).
Employment
-
Toronto Metropolitan University Adjunct Professor2025 - Present
-
Sri Ramachandra Institute of Higher Education and Research Professor2024 - Present
-
Sri Ramachandra Institute of Higher Education and Research (Deemed to be University) Associate Professor2020 - 2024
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (83)
- CAR-T Therapy for Kidney Cancer Save
- Room‐Temperature Accessible Stereospecific Synthesis of Methyl‐(Z)‐2‐(7‐methyl‐3‐oxo‐5H‐thiazolo[3,2‐a]pyrimidin‐2(3H)‐ylidene)acetates:Cd2+ Fluorescence Probe and DU145 Cell Study Save
- Prostate cancer theragnostics biomarkers: An update Save
- State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer Save
- Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells Save
- New insights on the early prostate cancer diagnosis in a real-world setting Save
- Nanomedicine-based cancer immunotherapy: recent trends and future perspectives. Save
- Preparation and characterization of an elastin nanogel with enhanced biocompatibility and improved entrapment efficiency in prostate cancer cells Save
- Suppression of Urokinase-Type Plasminogen Activator Receptor by Docosahexaenoic Acid Mediated by Heme Oxygenase-1 in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Human Endothelial Cells. Save
- A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer Save